iShares $ Corp Bond ETF USD Dist (LQDA)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 5.30 |
| Open | 5.28 |
| Bid | 5.43 x 3100 |
| Ask | 5.58 x 3200 |
| Day's range | 5.26 - 5.55 |
| 52-week range | 2.60 - 8.79 |
| Volume | |
| Avg. volume | 2,303,234 |
| Market cap | 350.131M |
| Beta (5Y monthly) | 0.27 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.80 |
| Earnings date | 04 Nov 2021 - 08 Nov 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 13.29 |
- Simply Wall St.
Trade Alert: The CEO & Director Of Liquidia Corporation (NASDAQ:LQDA), Roger Jeffs, Has Just Spent US$244k Buying 2.6% More Shares
Potential Liquidia Corporation ( NASDAQ:LQDA ) shareholders may wish to note that the CEO & Director, Roger Jeffs...
- Simply Wall St.
Liquidia (NASDAQ:LQDA) Is Using Debt Safely
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
- Motley Fool
Why Liquidia Stock Rocketed Nearly 21% Higher Today
One of the more volatile healthcare stocks of recent days, Liquidia Technologies (NASDAQ: LQDA), had quite the up session on Friday. Investors lifted the share price of the drug developer by almost 21%, following a series of relatively small but confidence-boosting insider buys. Liquidia has been an up-and-down stock due to developments on the legal front, specifically a patent infringement dispute it was engaged in against plaintiff United Therapeutics (NASDAQ: UTHR).
© 2022 Yahoo. All rights reserved.
